By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

Shares of Altimmune ( NASDAQ: ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Highmark cited exorbitant drug costs, higher medical utilization and sicker patients remaining in its Medicaid business for ...

If you've been on the internet at all over the last few months, you've more than likely heard of the drug Ozempic.

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Weight loss drugs like Ozempic deliver more health benefits than expected.

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...